Overview

Price




Price




Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Since its introduction, the BVA-100 Blood Volume Analyzer has been used in over 40,000 clinical cases and numerous research studies highlighting its potential to transform therapy. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions including heart failure and critical care by better informing treatment strategies, resulting in significantly better patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.


 Price History

 Useful Links

 Company Profile

350 Fifth Ave, Suite 4740
New York, NY 10118

212-330-8500

info@daxor.com


News


In the Spotlight

BioSpace:

Update on the Novel Coronavirus

MPO Magazine:

FDA-Cleared Blood Test Used to Guide COVID-19 Treatment

TechNetworks:

Maintaining Optimal Blood Volume in COVID-19 Patients

BioTuesdays:

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

MedGadget:

Blood Volume Analysis Using The BVA-100: Interview with Michael Feldschuh, Daxor CEO

BioWorld:

Blood Volume Assessment Study to use Daxor Device

Outsourcing-Pharma

Daxor Research Battles Military Injuries

BioSpace:

Update on the Novel Coronavirus

MPO Magazine:

FDA-Cleared Blood Test Used to Guide COVID-19 Treatment

TechNetworks:

Maintaining Optimal Blood Volume in COVID-19 Patients

BioTuesdays:

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

MedGadget:

Blood Volume Analysis Using The BVA-100: Interview with Michael Feldschuh, Daxor CEO

BioWorld:

Blood Volume Assessment Study to use Daxor Device

Outsourcing-Pharma

Daxor Research Battles Military Injuries

key contacts

Investor Relations

Bret Shapiro
CORE IR
377 Oak Street
Garden City, NY 11530
Phone: 516-222-2560
E-mail: brets@coreir.com
www.coreir.com

Transfer Agent

Continental Stock Transfer
1 State Street, 30th Floor
New York, NY 10004
Phone: 212-509-4000
E-mail: cstmail@continentalstock.com
www.continentalstock.com

Auditors

Withum Smith & Brown
1411 Broadway, 9th Floor
New York, NY 10018
Phone: 212-751-9100
Fax: 212-750-3262
E-mail: mstallone@withum.com
www.withum.com

Corporate Counsel

Peter Fetzer
Foley & Lardner LLP
777 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
Phone: 414-271-2400
Fax: 414-297-4900
www.foley.com

key contacts

The BVA-100 is an FDA-cleared diagnostic instrument to measure a patient’s blood volume, calculate an ideal blood volume that the patient should have, and indicate hypovolemia or hypervolemia with statistics showing the quality of results.

COPYRIGHT © 2018 DAXOR CORPORATION - ALL RIGHTS RESERVED.

Contact Us